BR6681517D0 - Processo para a obtencao de novas 4,5,6,7-tetraidro-tiazolo-5,4-c piridinas - Google Patents

Processo para a obtencao de novas 4,5,6,7-tetraidro-tiazolo-5,4-c piridinas

Info

Publication number
BR6681517D0
BR6681517D0 BR181517/66A BR18151766A BR6681517D0 BR 6681517 D0 BR6681517 D0 BR 6681517D0 BR 181517/66 A BR181517/66 A BR 181517/66A BR 18151766 A BR18151766 A BR 18151766A BR 6681517 D0 BR6681517 D0 BR 6681517D0
Authority
BR
Brazil
Prior art keywords
thiazolo
pyridines
tetrahydro
obtaining new
obtaining
Prior art date
Application number
BR181517/66A
Other languages
English (en)
Portuguese (pt)
Inventor
K Gmbh Thomae
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of BR6681517D0 publication Critical patent/BR6681517D0/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02Preparation by ring-closure or hydrogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • EFIXED CONSTRUCTIONS
    • E02HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
    • E02FDREDGING; SOIL-SHIFTING
    • E02F9/00Component parts of dredgers or soil-shifting machines, not restricted to one of the kinds covered by groups E02F3/00 - E02F7/00
    • E02F9/20Drives; Control devices

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Mining & Mineral Resources (AREA)
  • Civil Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Structural Engineering (AREA)
  • Molecular Biology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR181517/66A 1965-07-23 1966-07-22 Processo para a obtencao de novas 4,5,6,7-tetraidro-tiazolo-5,4-c piridinas BR6681517D0 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DET0029055 1965-07-23
DET0032992 1967-01-16
DET0032994 1967-01-16
DET0032993 1967-01-16
DET0032990 1967-01-16
DET0032991 1967-01-16

Publications (1)

Publication Number Publication Date
BR6681517D0 true BR6681517D0 (pt) 1973-12-27

Family

ID=27512321

Family Applications (1)

Application Number Title Priority Date Filing Date
BR181517/66A BR6681517D0 (pt) 1965-07-23 1966-07-22 Processo para a obtencao de novas 4,5,6,7-tetraidro-tiazolo-5,4-c piridinas

Country Status (7)

Country Link
BE (1) BE684415A (enrdf_load_stackoverflow)
BR (1) BR6681517D0 (enrdf_load_stackoverflow)
DE (1) DE1620508A1 (enrdf_load_stackoverflow)
ES (9) ES329299A1 (enrdf_load_stackoverflow)
FR (3) FR6013M (enrdf_load_stackoverflow)
GB (1) GB1140387A (enrdf_load_stackoverflow)
NL (2) NL6610324A (enrdf_load_stackoverflow)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847264A (en) * 1982-07-21 1989-07-11 Rorer Pharmaceutical Corporation Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
GB8333514D0 (en) * 1983-12-16 1984-01-25 Erba Farmitalia Tetrahydrothiazolo(5 4-c)pyridine derivatives
DE3680929D1 (de) 1985-02-06 1991-09-26 Boehringer Ingelheim Kg Verwendung des 2-amino-6-allyl-5,6,7,8-tetrahydro-4h-thiazolo(4,5-d)azepins zur herstellung eines zur behandlung der parkinsonschen erkrankung bzw. des parkinsonismus geeigneten arzneimittels.
GB2173187B (en) * 1985-03-23 1988-05-18 Erba Farmitalia Condensed 2-substituted thiazole derivatives
US5060904A (en) * 1987-05-01 1991-10-29 David Hegarty Multi-positionable support stand with movable center of gravity and article holding means
CA2314408A1 (en) * 1997-12-11 1999-06-17 Biochem Pharma Inc. Antiviral compounds
SE0001899D0 (sv) 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds
ES2346961T3 (es) 2001-11-22 2010-10-22 Biovitrum Ab Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa de tipo 1.
AR041952A1 (es) 2002-11-14 2005-06-01 Novartis Ag N-sulfonilaminotiazol
CL2004000553A1 (es) * 2003-03-20 2005-02-04 Actelion Pharmaceuticals Ltd Uso de compuestos derivados de guanidina como antagonistas del receptor de neuropeptido ff; compuestos derivados de guanidina; procedimientos de preparacion; y composicion farmaceutica que los comprende.
EP2266992A3 (en) 2003-11-12 2011-05-18 Daiichi Sankyo Company, Limited Process for producing thiazole derivative
CA2630718A1 (en) 2005-11-22 2007-05-31 Amgen Inc. Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
EP2379565A1 (en) * 2008-12-19 2011-10-26 Schering Corporation Piperidine and piperazine derivatives and methods of use thereof
EP2414340A1 (en) * 2009-04-03 2012-02-08 Dainippon Sumitomo Pharma Co., Ltd. Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
US11071721B2 (en) 2016-12-02 2021-07-27 Genentech, Inc. Bicyclic amide compounds and methods of use thereof
CR20200002A (es) 2017-07-14 2020-02-10 Hoffmann La Roche Compuestos de cetonas bicíclicas y métodos de uso de los mismos
MX2020003451A (es) * 2017-10-31 2020-08-03 Hoffmann La Roche Sulfonas y sulfoxidos biciclicos y metodos de uso de los mismos.
CN109134510A (zh) * 2018-11-13 2019-01-04 井冈山大学 制备2-氨基-5-cbz-4,5,6,7-四氢噻唑并[5,4-c]吡啶的新方法
WO2020146615A1 (en) 2019-01-11 2020-07-16 Genentech, Inc. Bicyclic pyrrolotriazolr ketone compounds and methods of use thereof

Also Published As

Publication number Publication date
ES329299A1 (es) 1968-02-16
ES349318A1 (es) 1969-04-01
ES349320A1 (es) 1969-04-01
ES349319A1 (es) 1969-04-01
NL6610324A (enrdf_load_stackoverflow) 1967-01-24
ES349314A1 (es) 1969-04-01
FR94123E (fr) 1969-07-04
GB1140387A (en) 1969-01-15
ES349317A1 (es) 1969-04-01
BE684415A (enrdf_load_stackoverflow) 1967-01-20
ES349316A1 (es) 1969-04-01
ES349321A1 (es) 1969-04-01
ES349322A1 (es) 1969-04-01
DE1620508A1 (de) 1969-09-18
NL6800589A (enrdf_load_stackoverflow) 1968-07-17
FR1498465A (fr) 1967-10-20
FR6013M (enrdf_load_stackoverflow) 1968-05-06

Similar Documents

Publication Publication Date Title
BR6681517D0 (pt) Processo para a obtencao de novas 4,5,6,7-tetraidro-tiazolo-5,4-c piridinas
BR6576150D0 (pt) Processo para a preparacao de 4-aril-isoflavanoides
BR6682746D0 (pt) Processo para a preparacao de novos derivados de ciclopentanofenantreno
BR6681446D0 (pt) Processo para a preparacao de nucleosideos
BR6684787D0 (pt) Processo para a preparacao de difenil-alcoil-aminas substituidas
BR6685453D0 (pt) Processo para a obtencao de novos derivados da desglucohelebrina
BR6676358D0 (pt) Processo para a obtencao de novos derivados de picolilamina
BR6911744D0 (pt) Processo para a preparacao de novas 5,10-dihidro-11 h-dibenzeno (b,e) (1,4) diazepin-11-onas substituidas em posicao 5
BR6685240D0 (pt) Processo para a obtencao de novos d-homoesteroides
BR6683054D0 (pt) Processo para a preparacao de diaminas
BR6682693D0 (pt) Processo para a preparacao de benzenossulfonilureias
BR6679318D0 (pt) Processo para a preparacao de benzenossulfo-nilsemicarbazidas
BR6678776D0 (pt) Processo para preparacao de imidazois
BR6684443D0 (pt) Processo para a preparacao de derivados de 1,4-benzodioxano
BR6679086D0 (pt) Processo para a producao de 3-substituido-5-(2-halogenoetil)-2-oxazolidinonas
BR6680680D0 (pt) Processo para a preparacao de oxaza-heterociclos
BR6682775D0 (pt) Processo para preparar novas 2-hidroxi-3-substituido propil 1,4-naftoquinonas
BR6679324D0 (pt) Processo para a obtencao de novas imidas ciclicas
BR6677313D0 (pt) Processo para a preparacao de insulina
BR6682173D0 (pt) Processo para a obtencao de novos derivados de 5-nitrofurila
BR6681685D0 (pt) Processo aperfeicoado para a obtencao de fenilacetonitrilas basicamente substituidas
BR6682929D0 (pt) Processo aperfeicoado para a producao de 7-cloro 13 diidro-1-metil-5-fenil-2h-1,4-benzodiazepin-2-ona
BR6680379D0 (pt) Processo de preparacao de novos derivados do dibenzocicloheptatrieno
BR6679622D0 (pt) Processo para a obtencao de derivados de 1-hidroxi-estradiol
BR6683163D0 (pt) Processo para a obtencao de 5-beta-h-6-ceto-14 alfa -delta 7-hidroxiesteroides